Patricia Zerr

Patricia ZERR is Director of Development at Domain Therapeutics. She joined the company in 2018 to structure the development team to support the transition of the pipeline toward the clinic. Before joining Domain, she spent nine years at Transgene (NASDAQ: TRGNF) where she led the global development of immunotherapeutic products up to phase IIb and co-structured a joint venture with Tasly, Transgene’s Chinese partner, and served as a strategic alliance manager. Between 2004 and 2008, she was the development project leader at Faust Pharmaceuticals. Patricia started her career at Forenap Phama as a clinical project manager, after two postdocs at OHSU Portland OR and Roche, Switzerland. She holds a Ph.D. in Neurosciences from the University of Strasbourg, France, and an MBA from HEC Paris Business School.